top of page
News, Events and Updates
Search
Aug 6, 2019
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Study Updates
Aug 1, 2019
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, 8/7/2019
Jul 30, 2019
Anavex Life Sciences Reports Recent Data Review by the Independent Data Safety Monitoring Board
Jul 29, 2019
Anavex Life Sciences Receives Positive Opinion for Orphan Designation from European Medicines Agency
Jul 16, 2019
Anavex Life Sciences Presents New Clinical Data Identifying Gut Microbiota Biomarkers
Jun 24, 2019
Anavex Life Sciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of ANAVEX®2-73
Jun 5, 2019
Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73
May 7, 2019
Anavex Life Sciences Reports Fiscal 2019 Second Quarter Financial Results, Updates on Clinical Study
May 7, 2019
Rett Syndrome Association of Australia and Anavex Life Sciences Initiate Phase 2 AVATAR Study
May 5, 2019
Anavex Life Sciences to Announce Fiscal 2019 Second Quarter Financial Results on Wednesday, 5/8/2019
Apr 4, 2019
Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference
16
17
18
19
20
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
